GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » Cyclically Adjusted PB Ratio

Mesoblast (Mesoblast) Cyclically Adjusted PB Ratio : 0.76 (As of May. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Mesoblast Cyclically Adjusted PB Ratio?

As of today (2024-05-22), Mesoblast's current share price is $0.675. Mesoblast's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.89. Mesoblast's Cyclically Adjusted PB Ratio for today is 0.76.

The historical rank and industry rank for Mesoblast's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEOBF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.16   Med: 0.57   Max: 1.37
Current: 0.68

During the past years, Mesoblast's highest Cyclically Adjusted PB Ratio was 1.37. The lowest was 0.16. And the median was 0.57.

MEOBF's Cyclically Adjusted PB Ratio is ranked better than
70.97% of 651 companies
in the Biotechnology industry
Industry Median: 1.71 vs MEOBF: 0.68

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Mesoblast's adjusted book value per share data for the three months ended in Dec. 2023 was $0.501. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.89 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mesoblast Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Mesoblast's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Cyclically Adjusted PB Ratio Chart

Mesoblast Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.31 0.36 0.65

Mesoblast Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.65 - 0.19 -

Competitive Comparison of Mesoblast's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Mesoblast's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mesoblast's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mesoblast's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mesoblast's Cyclically Adjusted PB Ratio falls into.



Mesoblast Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mesoblast's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.675/0.89
=0.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesoblast's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Mesoblast's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.501/126.3989*126.3989
=0.501

Current CPI (Dec. 2023) = 126.3989.

Mesoblast Quarterly Data

Book Value per Share CPI Adj_Book
201306 1.889 95.473 2.501
201312 1.887 97.330 2.451
201406 1.692 98.352 2.175
201412 1.693 99.002 2.162
201503 0.000 99.187 0.000
201506 1.317 99.838 1.667
201509 0.000 100.302 0.000
201512 1.217 100.673 1.528
201603 1.179 100.488 1.483
201606 1.300 100.859 1.629
201609 1.266 101.602 1.575
201612 1.193 102.159 1.476
201703 1.185 102.624 1.460
201706 1.142 102.809 1.404
201709 1.128 103.460 1.378
201712 1.159 104.110 1.407
201803 1.114 104.574 1.346
201806 1.080 104.945 1.301
201809 1.036 105.410 1.242
201812 1.000 105.967 1.193
201903 0.959 105.967 1.144
201906 0.921 106.617 1.092
201909 0.903 107.174 1.065
201912 0.885 107.917 1.037
202003 0.861 108.289 1.005
202006 0.897 106.246 1.067
202009 0.872 107.917 1.021
202012 0.838 108.846 0.973
202103 0.880 109.496 1.016
202106 0.851 110.332 0.975
202109 0.819 111.168 0.931
202112 0.783 112.654 0.879
202203 0.754 115.069 0.828
202206 0.725 117.112 0.782
202209 0.673 119.248 0.713
202212 0.644 121.477 0.670
202303 0.621 123.148 0.637
202306 0.585 124.170 0.596
202309 0.000 125.656 0.000
202312 0.501 126.399 0.501

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mesoblast  (OTCPK:MEOBF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mesoblast Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Mesoblast's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mesoblast (Mesoblast) Business Description

Industry
Traded in Other Exchanges
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.